As featured on:
A multi-disciplinary team that has the expertise to solve complex problems, a passion to make a positive impact on our world, and a sense of urgency to bring hope to the human race.
fluidIQ, a public benefit and Delaware corporation, provides simple yet elegant solutions based on proprietary fluidics technology. The company was founded by a group of doctors, engineers and patient advocates who joined together to find solutions for gaps in medical needs, including ventilators, in the midst of the coronavirus-caused world crisis. fluidIQ aims to deliver hope to a world in need with simple, easy-to-deploy technology solutions that solve the most pressing medical challenges of our time. fluidIQ’s roadmap for an entire family of products is based on its proprietary platform of fluidics-operated devices dedicated to filling gaps in emergency and preparedness protocols that are user-friendly, scalable and cost-effective.
A team of emergency and respiratory doctors, patient advocates and engineers, who came together in the early days of the pandemic, founded fluidIQ a public benefit corporation (PBC) domiciled in Delaware. The unique group of experts joined informally in March 2020, to develop simple-to-use emergency devices that require no electricity, harness the science of fluidics and solve some the world’s most pressing problems. In fact, the company’s name, fluidIQ, is based on the concept of “fluid intelligence” described as “taking separate areas of expertise and applying them to new problems.”
fluidIQ is developing technologies that use clever design to direct airflow using a science called “fluidics” to operate without electricity. Fluidics uses the flows and pressures of fluids or air to control operations normally performed by battery powered or electronic devices, without moving parts or electricity.
fluidIQ’s first entrant will be in the medical space providing what they believe is the world’s smallest mechanical ventilation device, filling unmet clinical and safety needs in countries around the world. This handheld resuscitation device was designed to be well-suited for use by EMS and first responders, providing breathing assistance to patients who are struggling to breathe or providing full breathing support for patients who are not breathing on their own when emergency help arrives.
inVent™, a device the size of a tube of lipstick, is also designed to meet demands for limited weight, space and ruggedness in stockpiling for disaster preparedness.
In the words of our late founding CEO, Chris Jung, “Our multi-disciplinary team has the expertise to solve complex problems, a passion to make a positive impact on our world and a sense of urgency to bring hope to the human race.”
We are passionate about our work and committed to making a difference in the lives of people in crisis and those seeking to help them. We are inspired to boldly address gaps in medical need with a strong scientific curiosity and a commitment to be better humans every day.
To revolutionize medical care with elegant, low cost, effective devices that improve lives and save humanity.
The problem: The current standard of care in emergency resuscitation is a 70-year-old manual technology that requires both hands of the responder and has multiple other limitations, the most important of which is the inadvertent damage they can do to patients’ lungs.
The solution: Our lipstick-sized automatic resuscitator is aimed at disrupting the emergency medical space by improving the lives of patients in crisis with lung protective ventilation. We support emergency medical providers by freeing up their hands to manage multiple patient needs. The HOPE inVent provides a simple yet elegant breathing support solution that requires no electricity or batteries and can be used in even the most resource scarce environments.
Solid state uni-body design and operation with no moving parts.
Provides gas powered automatic resuscitation, controlled by fluidics with exceptional consistency and reliability.
Cannot be altered or adjusted and is not subject to failure due to springs and valves. Set by clinical design and tested at the point of manufacture.
Tri-Device system to target the needs of EMS first responders from overdose to severe ARDS
Designed is suited for globally distributed manufacturing needs
Developed by a multi-national team of experts driven by simplification to provide the highest level of patient lung care
Disclaimer: Pending US FDA 510(k) clearance. Not available for sale in the U.S.
“Alone, we can do so little. Together, we can do so much.” — Helen Keller
Our team of doctors, engineers, patient advocates and industry experts came together in the early days of the pandemic. Combined, we have 200 years of experience in life sciences, engineering, startups and exits, commercialization and execution. At this stage in a typical startup lifecycle, having a team with this depth and breadth is highly uncommon. Together, our team is bringing disruptive technology to the emergency medicine market and bringing HOPE to the world.
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Technology Officer
Vice President Medical Affairs
Ph.D., RRT, FAARC, Chief of Clinical R&D
Lead Independent Board Of Directors
MD, Chief Medical Officer
DANA POINT, CA, USA, March 16, 2022 /EINPresswire.com/ — fluidIQ, a startup MedTech company developing fluidics-based respiratory solutions, announced today it has been chosen as an Innovation Leader for the LSI Emerging Medtech Summit in Dana Point, California happening this week. fluidIQ Chief Executive Officer, Matt Vogelhuber, RPh., will present today at 4:05 PM local time, marking the beginning of the company’s seed fundraising round.
WASHINGTON, January 25, 2022 —The Securing America’s Medicines and Supply Coalition (SAMS) announced today the addition of AmerisourceBergen and fluidIQ™ to its coalition of companies with the mission to strengthen the security of the medical supply chain in the United States. These new additions bring SAMS’s membership to six companies.
LEWES, DE, USA, January 21, 2022 /EINPresswire.com/ — fluidIQ, a startup MedTech company developing fluidics-based respiratory solutions, announced today Matt Vogelhuber, R.Ph. has been named its Chief Executive Officer. Vogelhuber served as interim CEO following the passing of the company’s founding CEO, Chris Jung, in November 2021.
NEWBURY PARK, CA, USA, November 22, 2021 /EINPresswire.com/ — fluidIQ, a startup MedTech company developing fluidics-based respiratory solutions, announced today Matt Vogelhuber will serve as interim Chief Executive Officer following the recent passing of founding CEO, Chris Jung. Teresa Barnes, the company’s President, has been appointed to the company’s board of directors.
NEWBURY PARK, CA, USA, November 2, 2021 /EINPresswire.com/ — Chris Jung, CEO of fluidIQ, a startup MedTech company launched in 2020, died unexpectedly on Tuesday. He was 42.
The mHUB MedTech Startup Pitch Competition was held virtually on Thursday, August 5th, 2021 to showcase disruptive MedTech startups founded by women and entrepreneurs of color. The pitch event was part of mHUB’s broader priority to increase the diversity in the hardtech and manufacturing sector, while creating a platform to highlight startups from across the country whose novel solutions can have a profound impact on patient care. Five finalists virtually pitched for cash prizes and industry connections in front of a group of esteemed judges from all across the MedTech sector.
FluidIQ placed second in the mHUB MedTech Startup Pitch Competition.